LHC Group, Inc. (NASDAQ:LHCG) COO Donald Dwayne Stelly sold 2,756 shares of LHC Group stock in a transaction on Friday, September 7th. The stock was sold at an average price of $99.32, for a total transaction of $273,725.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Donald Dwayne Stelly also recently made the following trade(s):

  • On Monday, June 11th, Donald Dwayne Stelly sold 3,307 shares of LHC Group stock. The stock was sold at an average price of $79.76, for a total transaction of $263,766.32.

Shares of NASDAQ:LHCG traded down $1.25 during midday trading on Friday, reaching $98.05. The company had a trading volume of 209,900 shares, compared to its average volume of 276,239. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.59 and a current ratio of 1.59. The company has a market capitalization of $3.10 billion, a P/E ratio of 41.27, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52. LHC Group, Inc. has a 52-week low of $58.65 and a 52-week high of $100.90.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Wednesday, August 1st. The health services provider reported $0.84 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.78 by $0.06. The company had revenue of $502.00 million for the quarter, compared to the consensus estimate of $509.03 million. LHC Group had a net margin of 3.75% and a return on equity of 8.33%. The firm’s quarterly revenue was up 95.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.63 EPS. research analysts predict that LHC Group, Inc. will post 3.52 earnings per share for the current year.

A number of equities analysts have issued reports on LHCG shares. Jefferies Financial Group lifted their price objective on shares of LHC Group to $120.00 and gave the stock a “buy” rating in a report on Friday, August 3rd. BidaskClub downgraded shares of LHC Group from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 10th. Benchmark set a $110.00 price target on shares of LHC Group and gave the stock a “buy” rating in a report on Thursday, August 2nd. ValuEngine raised shares of LHC Group from a “hold” rating to a “buy” rating in a report on Saturday, June 2nd. Finally, Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $96.00 price target on the stock in a report on Thursday, June 21st. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $93.89.

Large investors have recently modified their holdings of the stock. Vident Investment Advisory LLC lifted its holdings in LHC Group by 1.5% during the second quarter. Vident Investment Advisory LLC now owns 40,655 shares of the health services provider’s stock valued at $3,480,000 after purchasing an additional 609 shares during the last quarter. Cubist Systematic Strategies LLC lifted its holdings in LHC Group by 36.9% during the first quarter. Cubist Systematic Strategies LLC now owns 2,636 shares of the health services provider’s stock valued at $162,000 after purchasing an additional 711 shares during the last quarter. Meadow Creek Investment Management LLC lifted its holdings in LHC Group by 29.2% during the second quarter. Meadow Creek Investment Management LLC now owns 3,220 shares of the health services provider’s stock valued at $276,000 after purchasing an additional 728 shares during the last quarter. Xact Kapitalforvaltning AB lifted its holdings in LHC Group by 19.7% during the second quarter. Xact Kapitalforvaltning AB now owns 4,865 shares of the health services provider’s stock valued at $416,000 after purchasing an additional 800 shares during the last quarter. Finally, Glen Harbor Capital Management LLC lifted its holdings in LHC Group by 29.2% during the second quarter. Glen Harbor Capital Management LLC now owns 3,910 shares of the health services provider’s stock valued at $335,000 after purchasing an additional 884 shares during the last quarter. 87.08% of the stock is currently owned by institutional investors.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

See Also: How to Invest in an Index Fund

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.